FDA warns pharma companies for online ads
Pharma Compliance Alert, April 8, 2009
Fourteen pharmaceutical companies received warning letters from the FDA for “misleading” sponsored links on internet browsers.
The sponsored links are misleading because they make representations and/or suggestions about the efficacy of the products, but fail to communicate any risk information, according to the FDA letters.
GlaxoSmithKline, Forest Laboratories, Bayer, Cephalon, Pfizer, Novartis, Genentech, Boehringer Ingelheim, Merck, Eli Lilly, and Roche received warning letters for more than one product. Johnson & Johnson, Biogen Idec, and sanofi-aventis received warning letters for one product each. The FDA cited ads for a total of 48 products in the warning letters.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Medical Environment Update
Timely medical compliance news from OSHA, CDC, EPA, and other regulatory agencies!
-
Bloodborne Pathogens Training Video
Meets OSHA requirements for training employees on the bloodborne pathogens standard!
-
Hazard Communication Standard Training Video
Meets OSHA requirements for training employees on the Hazard Communication Standard!
-
Healthcare Marketing Advisor
Healthcare Marketing Advisor provides concise, time-saving strategies for branding, promoting, and advertising your...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Q/A: Coding for telescopic intraocular lens
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched